###begin article-title 0
STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy
###end article-title 0
###begin p 1
Conceived and designed the experiments: NNK PBR SPP MCP RRW. Performed the experiments: NNK PBR SPP DWG MB MYS TED MGB RFS HS MAB HJM. Analyzed the data: NNK PBR SPP DWG MB MYS TED MGB RFS HS MAB HJM RRW. Contributed reagents/materials/analysis tools: NNK PBR SPP MB MYS TED MGB RFS HS MAB HJM MCP RRW. Wrote the paper: NNK PBR SPP DWG HJM MCP RRW.
###end p 1
###begin p 2
Current address: Department of Surgery, Naval Medical Center, Portsmouth, Virginia, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constitutively activated IFN/STAT1 pathway suggest an association with an aggressive tumor phenotype. We hypothesized that tumor clones that constitutively overexpress this pathway are preferentially selected by the host microenvironment due to a resistance to STAT1-dependent cytotoxicity and demonstrate increased metastatic ability combined with increased resistance to genotoxic stress.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 292 298 292 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 482 483 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 477 483 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 515 520 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Here we report that clones of B16F1 tumors grown in the lungs of syngeneic C57BL/6 mice demonstrate variable transcriptional levels of IFN/STAT1 pathway expression. Tumor cells that constitutively overexpress the IFN/STAT1 pathway (STAT1H genotype) are selected by the lung microenvironment. STAT1H tumor cells also demonstrate resistance to IFN-gamma (IFNgamma), ionizing radiation (IR), and doxorubicin relative to parental B16F1 and low expressors of the IFN/STAT1 pathway (STAT1L genotype). Stable knockdown of STAT1 reversed the aggressive phenotype and decreased both lung colonization and resistance to genotoxic stress.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
Our results identify a pathway activated by tumor-stromal interactions thereby selecting for pro-metastatic and therapy-resistant tumor clones. New therapies targeted against the IFN/STAT1 signaling pathway may provide an effective strategy to treat or sensitize aggressive tumor clones to conventional cancer therapies and potentially prevent distant organ colonization.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Ries1">[1]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Langley1">[2]</xref>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
Metastasis is the primary cause of death in most cancer patients. The treatment of patients with metastatic disease in adult solid tumors remains largely palliative. The ineffectiveness of standard cancer therapies against metastatic disease is reflected by the marked disparity in survival from the time of diagnosis for localized versus distant disease [1]. This disparity is hypothesized to be due to a greater disease burden in patients with metastatic disease and the intrinsic resistance of metastatic disease to most cancer therapies. Metastasis resistance to conventional therapy is believed to be due to the multiple genetically unstable cell populations found within tumors [2]. Though there are many investigations into the mechanisms of metastasis, little is known regarding the mechanisms of metastatic progression that contribute to therapy resistance.
###end p 10
###begin p 11
###xml 318 321 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Dunn1">[3]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Dunn1">[3]</xref>
###xml 465 468 465 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Ikeda1">[4]</xref>
One key selection pressure shaping tumor cell evolution is the tumor microenvironment, which includes tumor cells, host stromal cells, extracellular matrix, and cells of the immune system. One component of the interaction between the tumor and the microenvironment is mediated by the immune system via "immunoediting" [3]. Immunoediting is proposed to be the process by which the immune system drives tumor cell selection towards an immune-resistant phenotype [3], [4], including resistance to the multiple host-secreted cytokines.
###end p 11
###begin p 12
###xml 69 72 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Kaplan1">[5]</xref>
A key cytokine in tumor-suppressive networks is IFN-gamma (IFNgamma) [5]. IFNgamma mediates its effect on cells by interacting with type II IFN receptors (IFNGR1 and IFNGR2). Upon receptor binding, IFNgamma activates the JAK/STAT1 dependent signaling pathway.
###end p 12
###begin p 13
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Shuai1">[6]</xref>
###xml 493 496 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Levy1">[7]</xref>
###xml 498 501 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Samuel1">[8]</xref>
STAT1, the first described member of the STAT transcription factor family [6], is the master transcription factor for IFN-related intracellular signaling and therefore tumor suppression related to IFNs. STAT1 is phosphorylated by JAK1/2 kinases at the Tyr701 position and then translocates to the nucleus where it binds to GAS (IFNgamma-activated sequence) promoter elements, thereby activating several hundred genes. These interferon-stimulated genes comprise the IFN/STAT1 signaling pathway [7], [8]. Therefore, the IFN/STAT1 pathway represents a signaling pathway that mediates crosstalk between the host microenvironmental components and the tumor cells.
###end p 13
###begin p 14
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Bhanoori1">[9]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Sironi1">[12]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Chin2">[13]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Townsend1">[14]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Stephanou1">[15]</xref>
###xml 574 578 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Huang1">[16]</xref>
Genes activated by STAT1 determine many of the functions related to the IFN/STAT1 pathway. Previous studies demonstrated that STAT1 controls anti-tumorigenic effects in part by up-regulation of caspases 1, 2, 3, 7, and 8 [9]-[12], cyclin-dependent kinase inhibitor 1A (CDKN1A) [13], the IFN-regulatory Factor 1 (IRF1)/p53 pathway [14], and down-regulation of the BCL2 (B-cell CLL/Lymphoma 2) family [15]. STAT1 also is involved in anti-angiogenic mechanisms, partially through the induction of IFNgamma-induced protein 10 (IP10 or CXCL10), thereby suppressing tumorigenesis [16].
###end p 14
###begin p 15
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 652 656 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 1016 1020 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Friedberg1">[19]</xref>
###xml 1040 1044 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Thomas1">[20]</xref>
###xml 1056 1060 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Roberts1">[21]</xref>
###xml 1096 1100 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fryknas1">[22]</xref>
###xml 1102 1106 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Rickardson1">[23]</xref>
###xml 1311 1315 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Hui1">[24]</xref>
###xml 1317 1321 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 1263 1271 <span type="species:ncbi:9606">patients</span>
In contrast, emerging data reveal that in certain cellular contexts the IFN/STAT1 pathway may mediate tumor cell growth. Previously, we demonstrated that a radioresistant tumor (Nu61), selected against fractionated ionizing radiation (IR) from a radiosensitive parental tumor SCC61, constitutively overexpresses the IFN/STAT1 pathway [17]. The nu61 radioresistant tumor and corresponding cell lines were also found to be resistant to IFN-mediated cytotoxicity [18]. A subsequent study demonstrated that selection of SCC61 against IFN-alpha (IFNalpha) and IFNgamma produced a similar IR- and IFN-resistant phenotype overexpressing the IFN/STAT1 pathway [18]. Thus, we concluded that resistance to IR and IFNs is associated with constitutive overexpression of the IFN/STAT1 pathway. Consistent with our observations are recent reports indicating that constitutive overexpression of STAT1 and STAT1-dependent genes is associated with protection of tumor cells from genotoxic stress following treatment with fludarabine [19], doxorubicin (Dox) [20], cisplatin [21], and the combination of IR and Dox [22], [23]. Overexpression of the IFN/STAT1 pathway is also associated with poor prognosis in different types of cancer and may have predictive value in breast cancer patients selected for the adjuvant chemotherapy [24], [25].
###end p 15
###begin p 16
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 435 439 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler1">[26]</xref>
###xml 440 444 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler3">[28]</xref>
###xml 450 453 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Langley1">[2]</xref>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
Based on these findings, we hypothesized that in vivo selection of developing tumor clones would be associated with the ability of tumor cells to overexpress the IFN/STAT1 pathway while resisting IFNgamma-mediated cytotoxicity. To test this hypothesis we used the syngeneic B16Fl mouse melanoma lung colonization model as a surrogate for metastatic propensity. This model was developed and described in detail by Fidler and colleagues [26]-[28] (see [2] for review). We investigated whether differences in phenotype between parental B16F1 and its derivatives passed through the lungs are related to IFNgamma-resistance, IFN/STAT1 pathway overexpression, and resistance to cytotoxic therapy including IR and chemotherapy.
###end p 16
###begin p 17
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 1059 1067 <span type="species:ncbi:9606">patients</span>
Here we report that tumor cells that constitutively overexpress the IFN/STAT1 pathway, and are thus resistant to the cytotoxic effects of this pathway, are preferentially selected for colonization by the lung microenvironment. Clones overexpressing this pathway produce a greater number of lung colonies compared to clones that do not constitutively overexpress the IFN/STAT1 pathway. We demonstrate the pre-existence of clones in the B16F1 tumor cell population that overexpress the IFN/STAT1 pathway. These clones are also resistant to IR and Dox. Suppression of STAT1 by stable knockdown using small hairpin RNA (shRNA) leads to a reversion of the phenotype, decreased ability to form lung colonies and decreased resistance to genotoxic stress. These data provide a mechanistic explanation for the STAT1-dependence of pro-metastatic and therapy-resistant tumor clones. We propose that overexpression of the IFN/STAT1 pathway contributes to therapy resistance and metastatic propensity leading to the poor response to traditional cancer therapy observed in patients with metastatic disease.
###end p 17
###begin title 18
Results
###end title 18
###begin title 19
Efficiency of lung colonization is accompanied by development of resistance to IFNgamma
###end title 19
###begin p 20
###xml 85 88 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 149 150 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 176 179 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 417 428 405 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A-B</bold>
###xml 417 428 405 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1A-B</bold></xref>
###xml 511 514 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 582 585 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Kaplan1">[5]</xref>
###xml 587 591 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Dighe1">[29]</xref>
###xml 593 597 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Street1">[30]</xref>
###xml 708 712 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler1">[26]</xref>
###xml 1109 1111 1081 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1113 1122 1085 1094 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1113 1122 1085 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1C</bold></xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
We examined lung colonization following injection of B16F1 melanoma cells in IFNgamma-/- mice compared with C57BL/6 controls. After injection of 5x104 B16F1 cells, 7/9 IFNgamma-/- mice developed lung colonies (mean number of lung colonies per mouse = 37.6+/-25.6). C57BL/6 mice developed significantly fewer lung colonies (7/16, number of lung colonies per mouse = 2.1+/-1.2; Student's two-tailed t-test; p = 0.0034; Figure 1A-B). These observations are consistent with prior reports demonstrating that IFNgamma-/- mice develop a greater number of lung colonies than wild type mice [5], [29], [30]. Passage of B16F1 cells through the lungs led to the formation of the highly metastatic daughter tumor B16F10 [26]. We suggested that such passages should lead to an increase in resistance to IFNgamma and we compared the sensitivity of B16F1 and B16F10 cells to IFNgamma with a MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay. We found that B16F10 cells were significantly more resistant to IFNgamma that B16F1 cells (Student's two-tailed t-test; p = 1.07x10-5; Figure 1C). Taken together these results confirm the importance of IFNgamma in suppressing B16F1 lung colonization and suggest that lung colonization is associated with resistance to IFNgamma.
###end p 20
###begin title 21
IFN/STAT1 signaling differs between tumor cell lines and is required for suppression of lung colonization.
###end title 21
###begin p 22
###xml 121 124 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 250 253 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 366 374 354 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
(A) Number of mice developing lung colonies and total number of lung colonies per mouse in C57BL/6 wild type and IFNgamma-/- mice after intravenous injection of B16F1 tumor cells (horizontal line represents mean). (B) Images of wild type and IFNgamma-/- explanted lungs demonstrate marked difference in number of lung colonies. (C) Differential response to IFNgamma in vitro between B16F1 (parental) and B16F10 (passaged, more aggressive) cell lines (mean+/-SD). (D) Variable fold-induction of IFN/STAT1 marker genes for eight cultured cell lines from P1 passage B16F1 lung colonies in C57BL/6 mice (numbers represent expression scores).
###end p 22
###begin title 23
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
Quantification of IFN/STAT1 pathway expression and definition of STAT1H and STAT1L genotype
###end title 23
###begin p 24
###xml 435 438 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Samuel1">[8]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Der1">[31]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Sanda1">[32]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Chi1">[33]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Zimmerer1">[36]</xref>
The IFN/STAT1 pathway mediates transduction of IFN signals into the nuclei of target cells. This transduction involves activation of Type I and Type II IFN receptors, receptor-associated JAK/TYK (tyrosine kinase) kinases and eventually activation and nuclear translocation of STAT1. IFN-mediated STAT1 transcriptional induction results in the transcription of several hundred genes designated the Interferon-Stimulated Genes (ISG; see [8], [31], [32] for reviews). To define a cut-off expression level to delineate high and low expressors of the IFN/STAT1 pathway we developed a method for rapid and efficient screening of cell lines and tumor clones. Prior studies demonstrate that activation of the IFN/STAT1 pathway can be measured by PCR-based quantification of gene expression using marker ISGs [33]-[36].
###end p 24
###begin p 25
###xml 25 37 25 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1, IFIT1</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFIT3</italic>
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFITM1</italic>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MX1</italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Feld1">[34]</xref>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MX1</italic>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Feld1">[34]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Sariol1">[35]</xref>
###xml 519 525 519 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFITM1</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Pellagatti1">[37]</xref>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFIT1</italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFIT3</italic>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Zimmerer1">[36]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Pellagatti1">[37]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 965 974 965 974 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 965 974 965 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s001"><bold>Figure S1</bold></xref>
###xml 1201 1205 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 1403 1407 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 1438 1457 1438 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1, IFIT1, IFIT3</italic>
###xml 1462 1465 1462 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MX1</italic>
###xml 1684 1688 1684 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Chi1">[33]</xref>
###xml 1690 1694 1690 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Paik1">[38]</xref>
###xml 1746 1747 1746 1747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1816 1823 1816 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
We selected five genes - STAT1, IFIT1 (interferon-induced protein with tetratricopeptide repeats 1), IFIT3 (interferon-induced protein with tetratricopeptide repeats 3), IFITM1 (interferon induced transmembrane protein 1), and MX1 (Myxovirus resistance protein 1) - to comprise our IFN/STAT1 pathway marker gene set based on following criteria. First, the literature confirms that these five genes are PCR-detectable markers of the IFN/STAT1 pathway. Specifically data have been published for STAT1[34], MX1[34], [35], IFITM1[37], IFIT1, and IFIT3[36], [37]. Secondly, we calculated the correlation between our DNA array data from our originally described interferon-related gene signature [17] with QRT-PCR (quantitative real time PCR) amplification data of 19 different ISGs included in this signature. Our results demonstrate that the five marker genes selected for the current study are located within the 95% confidence interval (Pearson's R = 0.803, p<0.001, Figure S1). Third, we tested these five IFN/STAT1 pathway marker genes in multiple cell lines and xenografts. We found that these five genes were amplified in response to IFNs and/or IR in 3 of 3 cell lines and 7 of 8 xenografts tested [18]. Finally, we recently reported a statistically derived seven-gene TSP (top scoring pair) classifier related to ISGs that is associated with poor prognosis and chemo- and radio-resistance in tumors [25]. Four out of seven TSP genes (STAT1, IFIT1, IFIT3 and MX1) overlap with our five-gene IFN/STAT1-pathway marker set (see above). Expression of each marker gene was normalized to B16F1 and the expression of all five genes was combined to generate our IFN/STAT1 expression score [33], [38]. This score was calculated as an average of the log2-transformed expression value for each of the five marker genes (see Methods for details) and was used to estimate the IFN/STAT1 pathway expression level in experimental cell lines and tumor clones.
###end p 25
###begin p 26
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT<sup>H</sup></italic>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT<sup>L</sup></italic>
###xml 284 293 284 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 284 293 284 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 293 298 293 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 298 307 298 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 298 307 298 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s002"><bold>Figure S2</bold></xref>
###xml 512 521 512 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 512 521 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 602 611 602 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 908 909 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 903 909 903 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 911 920 911 920 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 911 920 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 962 963 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 957 963 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 973 974 973 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 968 974 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 1044 1053 1044 1053 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1044 1053 1044 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 1110 1111 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1105 1111 1105 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 1121 1122 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 1116 1122 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 1195 1196 1195 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1190 1196 1190 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 1229 1238 1229 1238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1229 1238 1229 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 1287 1288 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1282 1288 1282 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 1352 1353 1350 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 1347 1353 1345 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
To test whether the expression score, as defined above, discriminates IFN/STAT1 pathway high (STATH) and low (STATL) expressors relative to B16F1 baseline, we performed QRT-PCR to profile eight cell lines from the P1 passage (B16F1 passed through the lungs of wild type C57BL/6 mice; Figure 1D and Figure S2). Three of these cell lines (P1M3D, P1M3E, and P1M7) demonstrated an up-regulation of the five-gene marker set relative to B16F1 and had positive IFN/STAT1 pathway expression scores (0.81, 1.21 and 0.89; Figure 1D). These cell lines were defined as overexpressors of IFN/STAT1 pathway (STAT1H; Figure 1D). The other five cell lines (P1M1, P1M4B, P1M4C, P1M5B and P1M8D) did not change or exhibited a down-regulation of the five-gene marker set relative to B16F1. These cell lines showed negative IFN/STAT1 pathway expression scores ranging from -0.13 to -0.9 and were defined as low expressors (STAT1L; Figure 1D). The difference between scores for STAT1H and STAT1L cell lines was significant (Student's two-tailed t-test; p = 0.0007; Figure 1D). We set the threshold expression score separating STAT1H and STAT1L genotypes at 0.8, which approximates the lowest score of the three STAT1H P1 cell lines (P1M3D cell line, Figure 1D). Subsequently, cell lines were designated STAT1H if their IFN/STAT1 pathway expression score was>/=0.8 and STAT1L if their IFN/STAT1 pathway expression score was <0.8.
###end p 26
###begin title 27
Constitutive overexpression of the IFN/STAT1 pathway is associated with B16 melanoma lung colonization
###end title 27
###begin p 28
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 555 563 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g002">Figure 2</xref>
###xml 609 610 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 604 610 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 825 827 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 829 837 823 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 829 837 823 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g002"><bold>Figure 2</bold></xref>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 766 771 <span type="species:ncbi:10090">mouse</span>
We tested the hypothesis that tumor clones overexpressing the IFN/STAT1 pathway (STAT1H) exhibit an increase in lung colonization compared to cells that do not overexpress this pathway (STAT1L). Three P1 STAT1H clones (P1M3D, P1M3E, and P1M7) were pooled as were three P1 STAT1L clones (P1M4B, P1M4C, and P1M5B) and then injected into mice. In the P2 group of mice injected with the P1 STAT1L clones, 7 of 10 animals developed 2.8+/-2.5 lung colonies per animal which is equivalent to the number of lung colonies for parental B16F1 (2.1+/-1.2; 7/16 mice; Figure 2). By contrast, P2 mice injected with P1 STAT1H clones showed a marked increase in both the frequency of colony formation (16/20 mice; Fisher's exact test; p = 0.023) and the number of lung colonies per mouse (31.0+/-31.8; Student's two-tailed t-test; p = 2.4x10-4; Figure 2). These data indicate that the expression level of the IFN/STAT1 pathway affects the ability of B16F1 cells to colonize the lungs following IV injection.
###end p 28
###begin title 29
Passage of B16 cell lines based on IFN/STAT1 pathway expression level coincides with an increase in number of lung colonies.
###end title 29
###begin p 30
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
(A) Number of lung colonies per mouse after intravenous injection of 5x104 tumor cells (horizontal line = mean number of lung colonies per mouse). (B) Representative images of lungs explanted from mice intravenously injected with 5x104 P2L, P2H, or P3H tumor cells, respectively.
###end p 30
###begin title 31
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
Propagation of the STAT1H genotype in tumor passages
###end title 31
###begin p 32
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 118 126 118 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g002"><bold>Figure 2</bold></xref>
###xml 126 131 126 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 131 140 131 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 131 140 131 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s002"><bold>Figure S2</bold></xref>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 228 229 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 240 249 240 249 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 240 249 240 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 399 408 399 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 399 408 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 597 598 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 600 608 598 606 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 600 608 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g002"><bold>Figure 2</bold></xref>
###xml 649 656 647 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 684 685 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 744 753 742 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 744 753 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 784 791 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 819 827 817 825 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 819 827 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s003"><bold>Table S1</bold></xref>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
The lung colonies produced by P1 STAT1H and P1 STAT1L cell lines were then used to generate a P2 panel of cell lines (Figure 2 and Figure S2). Nine cell lines were isolated from P2 STAT1L colonies and 25 cell lines from P2 STAT1H colonies (Figure 3A). The two cell lines from the P2H panel with the highest STAT1 expression score, P2M3C (expression score = 2.36) and P2M5A (expression score = 2.87; Figure 3A) were pooled and injected intravenously into mice. These two pooled cell lines produced lung colonies in 90% (9/10) of mice with 37.9+/-18.7 colonies per mouse (p = 0.0046 compared with P2L; Figure 2). Lung colonies derived from this third in vivo passage are indicated as P3H and 14 cell lines were cultured from these lung colonies (Figure 3A). All cell lines derived from in vivo passages are summarized in Table S1.
###end p 32
###begin title 33
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
IFN/STAT1 pathway expression level and frequency of STAT1H clones increases with passage number.
###end title 33
###begin p 34
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 253 261 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s003">Table S1</xref>
(A) Individual gene heat map and (B) STAT1 expression score of IFN/STAT1 pathway based on QRT-PCR expression levels for P1, P2L, P2H, and P3H cell lines. (C) Mean IFN/STAT1 pathway expression score for P1, P2L, P2H, and P3H cell lines (mean+/-SEM). See Table S1 for a description of cell lines and raw data.
###end p 34
###begin p 35
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 205 214 205 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003">Figure 3C</xref>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 337 338 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 332 338 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 349 350 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 396 397 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 391 397 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 422 423 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 464 465 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 459 465 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 529 530 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 524 530 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 588 589 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 583 589 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 638 643 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 707 718 705 716 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A-C</bold>
###xml 707 718 705 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A-C</bold></xref>
The mean STAT1 expression score shows a progressive increase from the P1 to the P3 passage with a significant difference between the P1 and P3 panels of cell lines (Student's two-tailed t-test; p = 0.006; Figure 3C). In the P1 cell lines, 3/8 (37.5%) of the cell lines exhibited a STAT1 expression score >/=0.8, classifying them as STAT1H. Of the P2L cell lines only 2/9 (22.2%) represented STAT1H genotype while in the P2H cell lines 11/25 (44%) belonged to STAT1H genotype. In the P3 cell lines 9/13 (69.2%) exhibited the STAT1H genotype. Thus, an increase in the frequency of the STAT1H cell lines and an increase in the mean level of STAT1 expression scores occurs during the progression from P1 to P3 (Figure 3A-C). These results indicate that B16F1 lung colony forming efficiency is significantly associated with expression levels of the IFN/STAT1 pathway.
###end p 35
###begin title 36
Tumor clones overexpressing IFN/STAT1 pathway pre-exist in B16F1 population
###end title 36
###begin p 37
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler4">[39]</xref>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 609 615 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 677 684 677 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 819 820 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 814 820 814 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 913 915 913 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 917 926 917 926 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 917 926 917 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4A</bold></xref>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
It was previously demonstrated that B16F1 cells have variable abilities to colonize the lungs due to preexisting heterogeneity of the tumor cell population [39]. It was suggested that the observed variability in B16F1 lung colonization proficiency might be connected with pathways that confer an increased capacity to colonize the lungs of C57BL/6 mice. In the current report we show that the ability to colonize the lungs is associated with constitutive overexpression of the IFN/STAT1 pathway (STAT1H genotype). We therefore hypothesized that the B16F1 cell population may contain pre-existent cells with a STAT1H genotype. To test this hypothesis we cloned B16F1 cells (see Methods) and investigated the expression levels of the IFN/STAT1 pathway in the progeny of monoclones. Five of 20 tested monoclones were STAT1H, and therefore overexpressed the IFN/STAT1 pathway (Student's two-tailed t-test; p = 5.33x10-5; Figure 4A).
###end p 37
###begin title 38
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
STAT1H variants pre-exist in the B16F1 population and the lung microenvironment stimulates the IFN/STAT1 pathway.
###end title 38
###begin p 39
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
(A) STAT1H variants pre-exist in a B16F1 population (red line represents expression score cutoff of 0.8 for STAT1H or STAT1L). (B) In vivo lung colonies have a markedly increased IFN/STAT1 pathway expression level compared with in vitro monoclones. (C) Induction of IFN/STAT1 pathway after in vitro co-culture of B16F1 with explanted lung tissue demonstrates a significant increase relative to B16F1 monocultures (p = 0.0174; mean+/-SD).
###end p 39
###begin p 40
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 292 301 292 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 292 301 292 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4B</bold></xref>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 358 367 358 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 358 367 358 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 391 400 391 400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 391 400 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4A</bold></xref>
We further compared in vitro monoclones to in vivo lung colonies with respect to expression of the IFN/STAT1 pathway. Eight lung colonies profiled in vivo demonstrated up-regulation of the IFN/STAT1 pathway from 60- to 120-fold relative to basal B16F1 in vitro depending on the marker genes (Figure 4B). On the contrary, STAT1H cell lines from the P1 panel (Figure 1D) and B16F1 monoclones (Figure 4A) exhibited up-regulation of the IFN/STAT1 pathway only 2 to 3-fold relative to baseline. These data indicate that the lung microenvironment uniformly up-regulates the IFN/STAT1 pathway in lung colonies.
###end p 40
###begin p 41
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev3">[40]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev4">[41]</xref>
###xml 390 399 390 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004">Figure 4C</xref>
###xml 538 546 538 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 577 586 577 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 577 586 577 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4B</bold></xref>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 803 810 803 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 910 914 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 916 920 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 925 933 921 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 925 933 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5</bold></xref>
###xml 1153 1154 1149 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1148 1154 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
To confirm that the observed pathway up-regulation was directly related to factors from the lung microenvironment, B16F1 was co-cultured with explanted lung tissue (see Methods and [40], [41]). B16F1 co-culture with explanted lung tissue led to a marked (4 to 37 fold) up-regulation of the IFN/STAT1 pathway compared with B16F1/B16F1 mono-culture (Student's two-tailed t-test; p  = 0.0174; Figure 4C). It is noteworthy that IFN/STAT1 pathway up-regulation in co-culture is similar to the difference in expression between B16F1 monoclones in vitro and P1 lung colonies in vivo (Figure 4B). Two important conclusions were made from these experiments. First, the population of B16F1 cells is heterogeneous with respect to the IFN/STAT1 pathway expression and contains pre-existing STAT1H variants prior to in vivo passage. According to our observations, these cells are likely resistant to IFNgamma cytotoxicity ([17], [18] and Figure 5). The second conclusion is that the lung microenvironment significantly up-regulates the IFN/STAT1 pathway in tumor clones, which may create a selection pressure and provide a survival advantage to the preexisting STAT1H clones that are inherently resistant to this cytotoxic microenvironment.
###end p 41
###begin title 42
Resistance to IFNgamma correlates with expression of IFN/STAT1 pathway.
###end title 42
###begin p 43
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 191 192 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 186 192 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 202 203 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 197 203 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 347 355 335 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s004">Table S2</xref>
(A) Survival of STAT1H and STAT1L cell lines relative to control B16F1 after treatment with 10 ng/ml of IFNgamma (horizontal line represents mean value). (B) Gene expression heat map of STAT1H and STAT1L cell lines used for IFNgamma resistance experiment. (C) Correlation between IFN/STAT1 pathway expression level and resistance to IFNgamma (see Table S2).
###end p 43
###begin title 44
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
STAT1H tumor clones are resistant to IFNgamma
###end title 44
###begin p 45
###xml 137 138 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 132 138 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 148 149 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 143 149 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 264 271 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 301 302 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 296 302 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 347 348 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 342 348 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 416 425 404 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 416 425 404 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5A</bold></xref>
###xml 425 427 413 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">; </bold>
###xml 427 435 415 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S2</bold>
###xml 427 435 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s004"><bold>Table S2</bold></xref>
###xml 504 505 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 499 505 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 518 527 502 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 518 527 502 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5B</bold></xref>
###xml 577 582 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 661 670 641 650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5C</bold>
###xml 661 670 641 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5C</bold></xref>
###xml 709 710 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 704 710 684 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 774 775 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 769 775 745 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
To test the hypothesis that overexpression of the IFN/STAT1 pathway in B16F1 cells correlates with IFNgamma resistance (see above), STAT1H and STAT1L cell lines from all three passages were challenged with 10 ng/mL of IFNgamma and viability assayed using MTS (see Methods). The mean viability of STAT1H clones was 16.02+/-6.7%, while that of STAT1L clones was 1.66+/-6.21% (Student's two-tailed t-test; p = 0.00001; Figure 5A; Table S2). Furthermore, IFNgamma-resistant cell lines co-clustered with STAT1H cell lines (Figure 5B). Lastly, there was a strong correlation between STAT1 expression score and resistance to IFNgamma (Pearson's R = 0.717; p = 0.0002; Figure 5C). These results demonstrate that STAT1H tumor clones are more resistant to IFNgamma compared with STAT1L tumor clones. Taken together with the data presented above, these findings indicate that overexpression of the IFN/STAT1 pathway is associated with resistance to IFNgamma.
###end p 45
###begin title 46
###xml 31 32 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 26 32 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
Resistance to IFNgamma in STAT1H tumor clones is also associated with resistance to ionizing radiation
###end title 46
###begin p 47
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 211 215 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 217 221 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 416 420 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 458 459 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 453 459 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
We previously reported that selection of the radioresistant tumor nu61 by in vivo fractionated IR was accompanied by overexpression of the IFN/STAT1 pathway and combined resistance to IR, IFNalpha, and IFNgamma [17], [18]. We also showed that selection of the sensitive parental tumor SCC61 against IFNalpha or IFNgamma led to constitutive overexpression of the IFN/STAT1 pathway and development of resistance to IR [18]. We therefore hypothesized that STAT1H B16 clones having an increased propensity to colonize the lungs and demonstrating resistance to IFNgamma, would also grow more rapidly and be resistant to IR.
###end p 47
###begin p 48
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 230 238 230 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 230 238 230 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3</bold></xref>
###xml 238 243 238 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 243 252 243 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s002"><bold>Figure S2</bold></xref>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 338 339 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 368 376 360 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 368 376 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5</bold></xref>
###xml 376 381 368 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 381 389 373 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S2</bold>
###xml 381 389 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s004"><bold>Table S2</bold></xref>
###xml 471 478 463 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 563 567 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Mauceri1">[42]</xref>
###xml 573 580 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 640 644 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Hallahan1">[43]</xref>
###xml 670 671 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 665 671 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 722 723 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 717 723 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 844 845 832 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 839 845 827 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 897 898 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 892 898 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 911 919 899 907 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 911 919 899 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g006"><bold>Figure 6</bold></xref>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
To test this hypothesis, we compared two cell lines derived from second generation lung colonies (P2) in which P2M3C was derived from pooled P1 STAT1H cell lines (P2H) and P2M6B was derived from pooled P1 STAT1L cell lines (P2L) (Figure 3 and Figure S2). Also, P2M3C (P2H) was previously shown to be resistant to IFNgamma, while P2M6B (P2L) was sensitive to IFNgamma (Figure 5 and Table S2). The parental B16F1 cell line was used as a control. Experiments were performed in vivo using hind limb injections of tumor cells into C57BL/6 mice as previously described [42] (see Methods). At day 13 after hind limb injection, the relative volume [43] of untreated P2M3C (STAT1H) tumors was 19.0+/-1.97 while that of P2M6B (STAT1L) was 12.0+/-1.92 (1.6-fold difference; Student's two-tailed t-test; p = 0.035). These data demonstrate that P2M3C (STAT1H) grew significantly faster compared to P2M6B (STAT1L) and B16F1 (Figure 6).
###end p 48
###begin title 49
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
STAT1H tumors are resistant to IR.
###end title 49
###begin p 50
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
STAT1H (P2M3C) tumors grow faster and are resistant to IR compared with STAT1L (P2M6B) and B16F1 parental tumors. (Vn/Vo = relative change in volume, day 0 = IR (20Gy), mean+/-SEM)
###end p 50
###begin p 51
###xml 245 253 241 249 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 245 253 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g006"><bold>Figure 6</bold></xref>
###xml 371 372 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 366 372 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 382 383 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 377 383 373 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 449 453 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
Tumors irradiated with 20 Gy demonstrated a similar trend. At day 21 after IR the relative tumor volume of irradiated P2M3C was 3.9 times larger (22.7+/-6.67) than the relative volume of P2M6B (5.8+/-1.78; Student's two-tailed t-test; p = 0.04; Figure 6). Thus, after a single dose of 20 Gy, the differences in relative volumes increased between tumors derived from STAT1H and STAT1L cell lines. Therefore, consistent with our previous observations [17], [18], tumors overexpressing the IFN/STAT1 pathway are resistant to both IR and IFNgamma.
###end p 51
###begin title 52
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
STAT1H clones demonstrate resistance to Doxorubicin
###end title 52
###begin p 53
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 528 537 528 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 528 537 528 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 575 576 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 570 576 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 601 610 601 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 601 610 601 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 891 892 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 886 892 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 905 913 905 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7</bold>
###xml 905 913 905 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g007"><bold>Figure 7</bold></xref>
###xml 962 963 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 957 963 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 1005 1006 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1000 1006 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 1141 1142 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 1136 1142 1132 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 1260 1261 1252 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 1255 1261 1247 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 1355 1365 1343 1353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3A</bold>
###xml 1355 1365 1343 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figures 3A</bold></xref>
###xml 1365 1367 1353 1355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 1367 1368 1355 1356 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</bold>
###xml 1367 1368 1355 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>5</bold></xref>
###xml 1368 1373 1356 1361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 1373 1381 1361 1369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S2</bold>
###xml 1373 1381 1361 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s004"><bold>Table S2</bold></xref>
###xml 1521 1529 1505 1513 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</bold>
###xml 1521 1529 1505 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figure 5</bold></xref>
###xml 1529 1534 1513 1518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 1534 1542 1518 1526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S2</bold>
###xml 1534 1542 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s004"><bold>Table S2</bold></xref>
###xml 1932 1936 1912 1916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 1938 1942 1918 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
We previously demonstrated that STAT1H tumors overexpressing the IFN/STAT1 pathway are resistant to Dox treatment and that constitutive expression of this pathway is predictive for response to adjuvant chemotherapy in patients with breast cancer [18], [25]. We hypothesized that the resistance of STAT1H tumor clones to Dox is linked to an impaired apoptotic response similar to our recent data for nu61 and SCC61 cell lines [18], [44]. To test this, we chose six cell lines, three of which were STAT1H (P3M2A, P2M3C and P3M5A; Figure 3A) and three cell lines that were STAT1L (P2M3, P2M6B and P2M5B; Figure 3A). Cells were treated with Dox for 24 hours and the apoptotic response was measured by activation of caspases 3/7 (see Methods). Dox activated caspases 3/7 in all the tested cell lines, but the three STAT1L cell lines had a significantly higher apoptotic response compared to STAT1H cell lines (Figure 7). The mean level of apoptosis induction in STAT1L cells was 34.1+/-5.7 fold, while in STAT1H cells it was 18.3+/-1.9 fold relative to untreated cells (Student's two-tailed t-test, p = 0.013). It is noteworthy that the two STAT1L cell lines with the maximal apoptotic response (P2M6B and P2M5B) were also sensitive to IFNgamma, while the two STAT1H cell lines with the minimal apoptotic response (P3M2A and P2M3C) were resistant to IFNgamma (Figures 3A, 5 and Table S2). P3M5A and P2M3 had intermediate levels of Dox-induced apoptosis and were characterized by intermediate levels of resistance to IFNgamma (Figure 5 and Table S2). These results support two conclusions. First, the STAT1-dependent development of tumor clones with an increased propensity for lung colonization and resistance to IFNgamma is associated with the development of resistance to Dox. Second, this resistance is linked to impaired apoptotic response through suppression of caspase 3/7 activation, which is consistent with our previous reports [18], [44].
###end p 53
###begin title 54
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
STAT1H cell lines are resistant to doxorubicin-induced apoptosis.
###end title 54
###begin p 55
###xml 158 159 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 153 159 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 169 170 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 164 170 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
Caspase 3/7 activation as a measure of apoptosis in cells exposed to doxorubicin (1 microM) for 24 hours (mean+/-SD, horizontal line represents mean for STAT1H and STAT1L groups). Data are presented as fold-induction relative to control (un-treated) cells.
###end p 55
###begin title 56
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
Development of tumor clones proficient in lung colonization and resistant to genotoxic stress is mechanistically connected to STAT1
###end title 56
###begin p 57
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 139 143 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 426 431 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 455 456 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 472 481 464 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 472 481 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3A</bold></xref>
###xml 481 486 473 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 486 494 478 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 486 494 478 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s003"><bold>Table S1</bold></xref>
###xml 504 509 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 571 578 563 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 585 592 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 697 702 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
Previously, we showed that stable knockdown of STAT1 in IR-resistant and IFNalpha/IFNgamma-resistant tumor cells led to radiosensitization [18], suggesting that STAT1 is one important mediator in the IR-resistant tumor phenotype. We used the same approach to test the hypothesis that STAT1 mediates the development of an aggressive pro-lung colonization phenotype as described here. We selected the cell line with the highest STAT1 score from the P2 STAT1H panel (P2M5A) (Figure 3A and Table S1). Stable STAT1 knockdowns of this cell line were generated using shRNA (see Methods). For in vivo colonization experiments, we tested P2M5A-24 and P2M5A-26 cell lines as they had maximal suppression of STAT1 with 6- and 12-fold suppression, respectively, as measured by QRT-PCR (results not shown).
###end p 57
###begin p 58
###xml 302 311 298 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8A</bold>
###xml 302 311 298 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g008"><bold>Figure 8A</bold></xref>
###xml 338 343 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 561 566 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 796 798 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 864 875 860 871 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8A-B</bold>
###xml 864 875 860 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g008"><bold>Figure 8A-B</bold></xref>
###xml 906 911 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 1035 1040 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
Lungs were explanted and colonies counted at two and three weeks after IV injection. P2M5A cells transfected with the control vector produced lung metastases in 100% of mice at two and three weeks with the mean number of lung metastases per mouse 94.3+/-6.5 at two weeks and 102+/-39.6 at three weeks (Figure 8A). Six-fold suppression of STAT1 with shRNA 24 led to a 4-5 fold suppression in lung colonization (Student's two-tailed t-test; p = 0.003), although 100% of mice still developed lung metastases at two and three weeks. However, 12-fold suppression of STAT1 with shRNA 26 corresponded to a 56-fold suppression (Student's two-tailed t-test; p = 0.0002) in lung colonization with a decrease in the incidence of lung metastases from 100% to 11% at two weeks (Fisher's exact test; p = 1.7x10-5) and 60% to 100% at three weeks (Fisher's exact test; p = 0.018; Figure 8A-B). These data demonstrate that STAT1 signaling is a key factor controlling the propensity for B16F1 melanoma cells to colonize the lung and that suppression of STAT1 can convert the tumor phenotype to poor lung colonizers.
###end p 58
###begin title 59
Knockdown of STAT1 using shRNA mitigates aggressive phenotype and restores sensitivity to doxorubicin.
###end title 59
###begin p 60
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
(A) Number of lung colonies per mouse produced by control-transfected (P2M5A-MT) and shRNA knockdown (P2M5A-24 and P2M5A-26) cell lines. Shown are data for 2 (white bars) and 3 (gray bars) weeks after IV injection (mean+/-SEM). (B) Representative images of lungs, colonized by respective cell lines. (C) Caspase 3/7 activation as a measure of apoptosis in control (P2M5A-MT) and shRNA knockdown (P2M5A-24 and P2M5A-26) cells exposed to doxorubicin (1 microM) for 24 hours.
###end p 60
###begin p 61
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 578 580 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-5</sup>
###xml 582 591 582 591 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8C</bold>
###xml 582 591 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g008"><bold>Figure 8C</bold></xref>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
Considering our previous observations of a relationship between expression of the IFN/STAT1 pathway, colonization propensity, and resistance to genotoxic stress, we investigated the effects of STAT1 knockdown in P2M5A (IFN/STAT1 pathway overexpressing) cells on the response to treatment with Dox. Knockdown of STAT1 by both shRNA constructs (24 and 26) led to a significant activation of apoptotic response following treatment with Dox compared with the control-vector transfected cell line as measured by activation of caspases 3 and 7 (Student's two-tailed t-test; p = 7.3x10-5; Figure 8C). These results are consistent with our previous finding that STAT1 knockdown causes tumor sensitization to genotoxic stress [18]. Taken together these results suggest that STAT1 plays an important role in the lung colonization ability of B16F1 clones and derivatives and that STAT1 provides a molecular link between colonization propensity and resistance of metastatic tumor clones to cytotoxic stimuli.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Perou1">[45]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Perou2">[46]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Chung1">[47]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 939 943 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
The relationship between overexpression of the IFN/STAT1 pathway and malignancy was initially described for breast tumors [45], [46]. Subsequently, Chung et al. compared gene expression patterns in lung and breast cancers and found two common functional clusters - a proliferation cluster and an IFN/STAT1 cluster [47]. However, the biological significance of overexpression of the IFN/STAT1 pathway remained unclear. We previously demonstrated an association between an IR-resistant phenotype and overexpression of IFN/STAT1 pathway in head and neck cancer cell lines [17]. Furthermore, stable transfection of STAT1 in the radiosensitive SCC61 cell line led to the formation of an IR- and IFN-resistant phenotype, thus confirming that constitutive overexpression of STAT1 conferred resistance to genotoxic stress. We then demonstrated that selection of SCC61 against IFNgamma and IFNalpha led to a similar IR- and IFN-resistant phenotype [18].
###end p 63
###begin p 64
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Buess1">[48]</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 684 692 <span type="species:ncbi:9606">patients</span>
These observations lead us to hypothesize that the development of tumor clones overexpressing the IFN/STAT1 pathway is associated with selection against IFNs, and perhaps other STAT1-activating ligands, secreted by the host microenvironment leading to the selection of cells resistant to the cytotoxic effects of transient STAT1 activation. This resistance is also associated with resistance to IR and chemotherapy, a characteristic of aggressive tumors [18], [25]. Indeed, in an ex vivo co-culture model it was demonstrated that stromal fibroblasts can secrete IFNs, activating the IFN/STAT1 pathway in breast cancer cells, and that this pathway is associated with poor prognosis in patients with breast cancer due to the development of metastases [48]. Our current data are consistent with these observations [25].
###end p 64
###begin p 65
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Our two most important findings reported here are that we demonstrate using an in vivo syngeneic model that the development of tumor clones within the host microenvironment leads to the preferential selection of clones constitutively overexpressing the IFN/STAT1 pathway with an associated improved ability to colonize the lung microenvironment. Second, we confirmed that these clones are resistant to genotoxic insult delivered by cytotoxic cytokines, IR, and chemotherapy. These findings raise questions about the potential role of the IFN/STAT1 pathway in metastasis development.
###end p 65
###begin p 66
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Gupta1">[49]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Gupta1">[49]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler5">[51]</xref>
Metastasis emerges as a result of genetic and epigenetic evolution driven by selection pressures created by the host microenvironment and within the tumor itself. A minority of cells from the heterogeneous tumor cell population survive these selection pressures (see [49] for review). The majority of tumor cells are eliminated during the metastatic cascade through multiple microenvironmental stresses including tissue barriers, regulation of nutrients and energy supplies through angiogenesis and hypoxia, interactions with the extracellular matrix, shear stresses within the bloodstream, networks of the cytotoxic cytokines, and tumor surveillance by the immune system (see [49]-[51] for reviews). As a result, only tumor cells with intrinsic properties that provide advantages in this multi-step selection process will survive and colonize distant sites. In this regard, we asked whether overexpression of the IFN/STAT1 pathway provides such a selective advantage to tumor cells, thereby leading to improved lung colonization.
###end p 66
###begin p 67
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler1">[26]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler3">[28]</xref>
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Langley1">[2]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Talmadge1">[52]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Der1">[31]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Sanda1">[32]</xref>
###xml 758 767 758 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 758 767 758 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 772 779 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 853 854 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 876 882 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 1062 1070 1062 1070 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 1062 1070 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s003"><bold>Table S1</bold></xref>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
To investigate these questions we used a syngeneic B16 mouse melanoma lung colonization model [26]-[28] (see [2] for review). Given the above mentioned data regarding the complexity and multi-stage nature of the metastatic process, we used the total number of surface lung colonies formed by the parental B16F1 and its derivatives as the endpoint to measure metastatic propensity. The individual lung colonies, which are believed to be the progeny of a single lung colonizing tumor cell [52], were used to establish cell lines in which we examined levels of expression of the IFN/STAT1 pathway. Also, given that IFN/STAT1 signaling involves hundreds of genes [31], [32], we used an expressional score calculated from the expression of five marker genes (see Figure 1D and Methods). This score allowed us to designate cell lines as high expressors (STAT1H) and low expressors (STAT1L) of the IFN/STAT1 pathway. The combination of these approaches allowed us to screen a panel of 55 cell lines representing three sequential passages of B16F1 through C57BL/6 mice (Table S1). We were then able to identify relationships between expression levels of the IFN/STAT1 pathway, resistance of tumor clones to cytotoxic agents, and the ability of tumor clones to colonize lungs.
###end p 67
###begin p 68
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 179 188 179 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 179 188 179 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figure 1D</bold></xref>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 316 324 316 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 316 324 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g002"><bold>Figure 2</bold></xref>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 413 420 413 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 603 609 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 810 819 806 815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 1</bold>
###xml 810 819 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g001"><bold>Figures 1</bold></xref>
###xml 819 824 815 820 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 824 825 820 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</bold>
###xml 824 825 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>3</bold></xref>
###xml 686 691 <span type="species:ncbi:10090">mouse</span>
###xml 803 808 <span type="species:ncbi:10090">mouse</span>
A striking observation was that after only the first passage (P1), established cell lines obtained from the lung colonies clearly segregated into the STAT1H and STAT1L genotypes (Figure 1D). Furthermore, STAT1H clones demonstrated a 10-fold increase in their ability to colonize the lungs compared to STAT1L clones (Figure 2). These results were further confirmed by propagation of STAT1H clones in the P2 and P3 in vivo passages demonstrating both increased frequency of STAT1H clones and an increase in the level of IFN/STAT1 pathway up-regulation. In parallel, in each passage the ratio of STAT1H to STAT1L clones increased. In the P1 passage we observed only 2.1+/-1.2 colonies per mouse, while in the P3 passage we observed an almost 20-fold increase in lung colonization (37.9+/-18.7 colonies per mouse; Figures 1 and 3). These results demonstrate that tumor clones with increased expression of the IFN/STAT1 pathway possess an aggressive phenotype with an enhanced ability to colonize the lungs.
###end p 68
###begin p 69
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler4">[39]</xref>
###xml 220 229 220 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 220 229 220 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4A</bold></xref>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 577 578 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 572 578 572 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 765 772 765 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 831 832 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 826 832 826 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 932 933 932 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 927 933 927 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 942 951 942 951 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 942 951 942 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g004"><bold>Figure 4B</bold></xref>
###xml 1081 1085 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Gupta1">[49]</xref>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler5">[51]</xref>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Podsypanina1">[53]</xref>
Previously, Fidler and Kripke demonstrated that some monoclones of B16F1 have preexistent abilities to aggressively colonize the lungs [39]. We used a similar approach but focused on expression of the IFN/STAT1 pathway (Figure 4A). We concluded that the population of B16F1 cells contains preexisting STAT1H variants prior to in vivo passage. According to our prior and current observations, these cells are resistant to cytotoxic and genotoxic stress, are selected by the lung microenvironment, and are more proficient at colonizing the lungs. Our results suggest that a STAT1H status is at least in part responsible for the preexistent ability of B16F1 cells to colonize the lungs. Additionally, we propose that significant up-regulation of the IFN/STAT1 pathway in vivo likely creates a negative selection pressure against STAT1L clones that are not resistant to the cytotoxic effects of this pathway, thereby selecting for STAT1H clones (Figure 4B). Importantly, our co-culture data suggest that the lung microenvironment likely plays a significant role in this selection (see [49], [51], [53]).
###end p 69
###begin p 70
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 94 103 90 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 5</bold>
###xml 94 103 90 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g005"><bold>Figures 5</bold></xref>
###xml 103 104 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</bold>
###xml 104 104 100 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g006"/>
###xml 104 105 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</bold>
###xml 104 105 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g007"><bold>7</bold></xref>
###xml 113 114 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 108 114 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 166 167 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 161 167 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 293 297 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 299 303 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 305 309 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Weichselbaum1">[25]</xref>
###xml 311 315 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 331 335 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fryknas1">[22]</xref>
###xml 682 686 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 247 252 <span type="species:ncbi:9606">human</span>
We tested the resistance of STAT1H and STAT1L cell lines and tumors to IFNgamma, IR, and Dox (Figures 5-7). STAT1H clones were resistant to all treatments while STAT1L clones were sensitive. This is consistent with our previous data obtained with human head and neck cell lines SCC61 and nu61 [17], [18], [25], [44]. Fryknas et al [22] showed that overexpression of the IFN/STAT1 pathway in myeloma cell lines is associated with cross-resistance to IR and Dox. Recent observations from our laboratory indicate that resistance to STAT1 is also associated with resistance to the death ligands of the TNF receptor superfamily that are also involved in the control of tumor development [44]. Therefore, it is reasonable to propose that once tumor cells of different types acquire resistance to the IFN/STAT1 pathway and are then selected based on this resistance, they are also intrinsically resistant to a wide variety of cytotoxic and genotoxic insults.
###end p 70
###begin p 71
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 212 218 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 238 246 238 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g003"><bold>Figure 3</bold></xref>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 398 406 398 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8</bold>
###xml 398 406 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g008"><bold>Figure 8</bold></xref>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 556 564 556 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 576 580 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fryknas1">[22]</xref>
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Hui1">[24]</xref>
###xml 777 782 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 896 904 896 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 920 925 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 1018 1023 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
Finally, to provide mechanistic evidence of the dependence of STAT1 on the observed aggressive STAT1H genotype, we generated stable STAT1 knockdowns in the P2M5A cell line, which was the highest overexpressor of STAT1H in the P2 passage (Figure 3). STAT1 knockdown completely reversed the tumor phenotype, significantly reducing lung colonization while significantly increasing sensitivity to Dox (Figure 8). These results are consistent with our previous report, in which stable knockdown of STAT1 in nu61 (STAT1H genotype) led to radiosensitization both in vitro and in vivo[18]. Fryknas et al [22] reported similar effects when inhibiting STAT1 in myeloma cell lines by fludarabine with sensitization to both IR and Dox. Most recently Hui et al [24] found overexpression of STAT1 in renal cell carcinoma relative to normal kidney cells and were subsequently able to radiosensitize tumor cells in vitro by suppressing STAT1 using siRNA or fludarabine. Taken together with our current results these data suggest that STAT1 is tightly associated with resistance to genotoxic stress and provides a promising target for radio-and chemo-sensitization of primary tumors and perhaps distant metastasis.
###end p 71
###begin p 72
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 654 660 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 716 722 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 731 739 731 739 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8</bold>
###xml 731 739 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005821-g008"><bold>Figure 8</bold></xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Kim1">[54]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Dunn2">[55]</xref>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Townsend2">[57]</xref>
The observation that constitutive overexpression of the IFN/STAT1 pathway confers aggressive and therapy resistant tumor clones leaves several unanswered questions which need to be explored including the mechanisms by which activation of the IFN/STAT1 pathway switches the pathway from "cytotoxic" to "pro-survival" and the mechanisms that underlie this switch. Recently, we reported that constitutive overexpression of the STAT1 pathway is associated with suppression of caspases 8, 9, and 3 and therefore with suppression of the apoptotic response in radiation and interferon resistant tumor cells [44]. In the current report we also demonstrated that STAT1H clones have an impaired apoptotic response compared to STAT1L clones (Figure 8). Taken together these results suggest that resistance to the IFN/STAT1 pathway is associated with impaired apoptosis. Our findings suggest that once cells become resistant to apoptosis they can survive activation of the pro-apoptotic branch of the IFN/STAT1 pathway [54]. Still, we cannot exclude that a mechanisms other than apoptosis may also lead to IFN/STAT1 pathway resistance [55]-[57].
###end p 72
###begin p 73
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Efimova1">[44]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCL1</italic>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Timofeeva1">[58]</xref>
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFITM1</italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu-13</italic>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Kita1">[59]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Steiner1">[60]</xref>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USP18</italic>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBP43</italic>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Malakhova1">[61]</xref>
###xml 520 533 520 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCL1, IFITM1,</italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USP18</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev1">[17]</xref>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
In a previous study we also suggested that due to the complexity of the network of STAT1-dependent genes, suppression of the cytotoxic branch of IFN/STAT1 pathway [44] may reveal STAT1-dependent genes with radioprotective and pro-survival functions [18]. Indeed, STAT1 has been reported to control pro-survival genes such as MCL1[58], IFITM1 or Leu-13[59], multidrug resistance vault proteins [60], and USP18 (UBP43), which mediate protection from IFN-induced cytotoxicity [61]. Importantly, we previously reported that MCL1, IFITM1, and USP18 are co-expressed with STAT1 in the IR- and IFN-resistant nu61 tumor [17]. We believe that systematic profiling of STAT1 knockdowns combined with biological validation will reveal the essential and potentially oncogenic genes controlled by STAT1.
###end p 73
###begin p 74
Overall our current data demonstrate that B16F1 syngeneic model of lung metastasis supports our hypothesis that the overexpression of the IFN/STAT1 pathway is an important mediator in the development of an aggressive lung colonizing phenotype that is resistant to negative selection pressures from the lung microenvironment and concurrently resistant to conventional cancer therapy including IR and chemotherapy. Future experiments are needed to elucidate the mechanistic functions of STAT1 that confer this aggressive and therapy-resistant phenotype. Recent reports and our current observations strongly suggest that STAT1 provides a promising target for sensitization of primary tumors and perhaps distant metastasis to anti-tumor therapy.
###end p 74
###begin title 75
Methods
###end title 75
###begin title 76
Cell culture
###end title 76
###begin p 77
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 645 649 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 207 213 <span type="species:ncbi:9913">bovine</span>
B16F1 and B16F10 murine melanoma cell lines were obtained from the American Type Culture Collection (Manassas, VA) and were cultured in RPMI 1640 media (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 100 U/mL penicillin, and 100 mg/mL streptomycin (Invitrogen, Carlsbad, CA). Parental B16F1 cell lines and daughter cell lines, obtained after in vivo passages, were maintained in culture with the same media with 5% CO2 at 37degreesC or stored in liquid nitrogen. For generation of STAT1 knockdowns we used commercial shRNA constructs (Sigma, Saint Louis, MI), as described elsewhere [18]. Cells were cultured the same as parental B16F1 with the addition of 1 mg/ml of puromycin.
###end p 77
###begin title 78
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 78
###begin p 79
###xml 87 92 83 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Ts</sup>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
C57BL/6-Ncr mice were obtained from FCRI-Taconic (Germantown, NY) and B6.129S7-IFNgammatm1Ts-/- (IFNgamma-null phenotype) were obtained from Jackson Laboratories (Bar Harbour, ME). Animals were 5-7 weeks of age at the beginning of all experiments. The care and treatment of experimental animals was in accordance with institutional guidelines at the University of Chicago.
###end p 79
###begin title 80
Tumor cell injections
###end title 80
###begin p 81
###xml 392 393 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 429 434 <span type="species:ncbi:10090">mouse</span>
C57BL/6 mice were injected i.v. via the internal jugular (IJ) vein or tail vein with tumor cells. For the IJ injections mice were anesthetized with a Ketamine mixture. After shaving the neck/clavicular area, the skin was incised and vein dissected free. 100 mL of cellular suspension was delivered under direct visualization and without spillage. Cyanoacrilate was used for skin closure. 5x104 tumor cells were injected i.v. per mouse.
###end p 81
###begin title 82
Selection of cell lines from IFN/STAT1-expressing tumor colonies
###end title 82
###begin p 83
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Fidler1">[26]</xref>
###xml 503 510 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 527 528 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 725 726 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 720 726 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 739 740 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 791 792 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 799 800 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 863 870 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 906 907 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 933 942 933 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 933 942 933 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s002"><bold>Figure S2</bold></xref>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
We followed the model of experiments from Fidler and colleagues [26] with the addition of screening established cell lines for expression of IFN/STAT1 pathway genes. Parental B16F1 cell lines were injected in C57BL/6 mice and lung colonies were harvested using gross dissection techniques. Each colony was divided with one half used for QRT-PCR profiling and the other half used for establishment of the primary cell lines (P1 panel). QRT-PCR profiling of the P1 panel IFN/STAT1 pathway is described in Methods Section 6. STAT1H (high expressors) and STAT1L (low expressors) P1 cell lines were separately pooled and injected into the next group of mice to generate the P2 panel of cell lines. To represent progeny of P1 STAT1H and P1 STAT1L cell lines the P2 cell lines were designated as P2H and P2L, respectively. Finally, P2H cell lines were pooled and passed in vivo as described above to generate a P3H panel of cell lines (See Figure S2 for a schematic representation).
###end p 83
###begin title 84
Collection of cell lines and in vivo samples
###end title 84
###begin p 85
###xml 348 355 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 390 391 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
One-half of each lung colony was placed into an Eppendorf tube, snap-frozen in liquid nitrogen, and transferred to a -80degreesC freezer. The other half of each sample was used to establish an independent cell line. To accomplish this the lung colony fragment was placed into a single well of a 24-well plate, covered by 1 ml of culture media (see Methods section 1), and incubated in 5% CO2 at 37degreesC until a monolayer of cells, morphologically similar to B16F1, was apparent under microscopic observation. The lung colony fragment was removed, the cells were detached by trypsinization, and then the cells were transferred to parallel 24-well plates and cultured for 2-4 days. Cell cultures that produced a consistent confluent monolayer were collected, frozen, and used in the subsequent experiments. All established cell lines were stored in liquid nitrogen.
###end p 85
###begin title 86
IFN/STAT1 pathway scoring system based on QRT-PCR profiling
###end title 86
###begin p 87
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Khodarev2">[18]</xref>
###xml 217 225 217 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S3</bold>
###xml 217 225 217 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005821.s005"><bold>Table S3</bold></xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Kimchi1">[62]</xref>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G<sub>i</sub></italic>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">log<sub>2</sub>R</italic>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
To quantify IFN/STAT1 pathway expression levels in multiple samples using QRT-PCR, we used a five gene marker set (STAT1, IFIT1, IFIT3, IFITM1, and MX1) (see [18]). Primers for the mouse marker genes are presented in Table S3. The QRT-PCR technique used in these experiments is previously described [62]. For calculation of the IFN/STAT1 pathway expression score (ES) we used the equation , where Gi = log2R, R = fold ratio relative to B16F1, and n = number of genes.
###end p 87
###begin title 88
Resistance to IFNgamma
###end title 88
###begin p 89
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 89 95 <span type="species:ncbi:10090">murine</span>
Cell lines were plated in 96-well plates (5x103 cells/well) and treated with 10 ng/ml of murine IFNgamma (R&D Systems, Minneapolis, MN). 48 hours later cell survival was determined using the Promega CellTiter 96* Nonradioactive Cell Proliferation Assay (MTT) (Promega, Madison, WI) according to the manufacturer's instructions. Viability was calculated relative to a B16F1 control.
###end p 89
###begin title 90
Resistance to ionizing radiation
###end title 90
###begin p 91
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Mauceri1">[42]</xref>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005821-Mauceri1">[42]</xref>
###xml 762 763 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
In vivo radioresistance of STAT1H and STAT1L cell lines was determined as previously described [42]. Briefly, B16F1, P2M3C (STAT1H), and P2M6B (STAT1L) were injected subcutaneously (1x107 cells in 100 ml PBS) into the right hind limb of C57BL/6 mice. Five to seven days after injection the tumor volume was 150-200 mm3. At the initiation of treatment (day 0) animals were divided into appropriate treatment groups and randomized with respect to the tumor size. A single dose of 20 Gy was delivered using a Phillips orthovoltage X-ray generator operating at 250 kV 15 mA. Tumor volume was determined by direct measurement with calipers and calculated by the formula (lengthxwidthxdepth/2 [42]. At the conclusion of each experiment animals were euthanized using CO2 followed by cervical dislocation in accordance with the institutional guidelines.
###end p 91
###begin title 92
Sensitivity to Doxorubicin and apoptosis measurement
###end title 92
###begin p 93
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sup>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>L</sup></italic>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
To test the effects of IFN/STAT1 pathway expression levels on the apoptotic response to Dox we used three STAT1H cell lines (P3m2a, P2m3c, P3m5a) and three STAT1L cell lines (P2m3, P2m6b, and P2m5b). We selected one STAT1H cell line (P2m5a) and generated STAT1 knockdowns (see above) that were also tested for Dox sensitivity. Cells were plated at a density of 5x103 cells per well in 96-well plates in triplicates for 24 hours and then treated with 1.0 microM Dox for 24 hours. Apoptosis was measured using the Promega Caspase-Glo 3/7 assay (Madison, WI). Luminescence was measured 30 minutes after addition of the Caspase-Glo reagent using a TD-20/20 Luminometer. Signal intensities for treated samples were background (no cells) subtracted and divided by the intensity of an untreated control to calculate relative induction of apoptosis.
###end p 93
###begin title 94
Co-culture of B16F1 with C57BL/6 lung tissue
###end title 94
###begin p 95
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 230 231 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
B16F1 cells were plated in triplicate at a density of 1x106 per well in a 6-well plate and incubated for 24 hours. 0.4 microm polyester membrane transwell inserts (Costar 3450, Corning, NY) were placed on top of each well and 1x106 B16F1 cells (mono-culture) or lung tissue removed from C57BL/6 mice that was rinsed with warm PBS (co-culture) were added. B16F1 cells on the bottom of the wells were removed after 8 and 24 hours of mono- or co-cultured incubation. Expression of the IFN/STAT1 pathway was measured relative to B16F1 monoculture as described above.
###end p 95
###begin title 96
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sup>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1<sup>H</sup></italic>
Detection of pre-existing STAT1H clones
###end title 96
###begin p 97
B16F1 cells were plated at 1 cell/well (monoclones) in a 96-well plate (Nunclon Surface, Denmark). After one week of growth, colonies were transferred to 24-well plates and grown to confluence. 20 monoclone cultures were collected using Trizol reagent and analyzed using QRT-PCR. Scoring and quantitative estimation of the data are described above.
###end p 97
###begin title 98
Supporting Information
###end title 98
###begin p 99
Correlation between gene array expression levels and QRT-PCR expression levels. Marker genes used for IFN/STAT1 expression score are labeled. Dashed line  =  95% confidence interval.
###end p 99
###begin p 100
(0.19 MB PPT)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
Schematic representation of B16 P1, P2H, P2L, and P3H passages. Note that steps within circle were repeated for each passage to characterize lung colonies using QRT-PCR for IFN/STAT1 pathway expression scores and to develop stable cell lines in vitro.
###end p 102
###begin p 103
(0.20 MB PPT)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
STAT1 individual marker gene QRT-PCR levels and overall IFN/STAT1 pathway expression score for all cell lines relative to B16F1.
###end p 105
###begin p 106
(0.12 MB DOC)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
IFNI3 resistance and STAT1 expression score for cell lines tested.
###end p 108
###begin p 109
(0.03 MB DOC)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
IFN/STAT1 marker gene QRT-PCR primers
###end p 111
###begin p 112
(0.03 MB DOC)
###end p 112
###begin p 113
Click here for additional data file.
###end p 113
###begin p 114
The authors are grateful to Dr. Samuel Hellman for his helpful discussion of this manuscript.
###end p 114
###begin title 115
References
###end title 115
###begin article-title 116
Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.
###end article-title 116
###begin article-title 117
Cancer immunoediting: from immunosurveillance to tumor escape.
###end article-title 117
###begin article-title 118
The roles of IFN gamma in protection against tumor development and cancer immunoediting.
###end article-title 118
###begin article-title 119
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
###end article-title 119
###begin article-title 120
Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.
###end article-title 120
###begin article-title 121
Stats: transcriptional control and biological impact.
###end article-title 121
###begin article-title 122
Antiviral actions of interferons.
###end article-title 122
###begin article-title 123
Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1).
###end article-title 123
###begin article-title 124
Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis.
###end article-title 124
###begin article-title 125
Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy.
###end article-title 125
###begin article-title 126
STAT1-induced apoptosis is mediated by caspases 2, 3, and 7.
###end article-title 126
###begin article-title 127
Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.
###end article-title 127
###begin article-title 128
STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis.
###end article-title 128
###begin article-title 129
Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters.
###end article-title 129
###begin article-title 130
Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells.
###end article-title 130
###begin article-title 131
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.
###end article-title 131
###begin article-title 132
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.
###end article-title 132
###begin article-title 133
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.
###end article-title 133
###begin article-title 134
STAT1: a modulator of chemotherapy-induced apoptosis.
###end article-title 134
###begin article-title 135
###xml 84 89 <span type="species:ncbi:9606">human</span>
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.
###end article-title 135
###begin article-title 136
STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines.
###end article-title 136
###begin article-title 137
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.
###end article-title 137
###begin article-title 138
Radiosensitization by Inhibiting STAT1 in Renal Cell Carcinoma.
###end article-title 138
###begin article-title 139
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.
###end article-title 139
###begin article-title 140
Selection of successive tumour lines for metastasis.
###end article-title 140
###begin article-title 141
Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
###end article-title 141
###begin article-title 142
Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
###end article-title 142
###begin article-title 143
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.
###end article-title 143
###begin article-title 144
Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.
###end article-title 144
###begin article-title 145
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
###end article-title 145
###begin article-title 146
Differential gene induction by type I and type II interferons and their combination.
###end article-title 146
###begin article-title 147
###xml 102 107 <span type="species:ncbi:9606">human</span>
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.
###end article-title 147
###begin article-title 148
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.
###end article-title 148
###begin article-title 149
###xml 111 126 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 132 151 <span type="species:ncbi:11053">dengue virus type 1</span>
Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.
###end article-title 149
###begin article-title 150
###xml 64 71 <span type="species:ncbi:9606">patient</span>
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.
###end article-title 150
###begin article-title 151
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
###end article-title 151
###begin article-title 152
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
###end article-title 152
###begin article-title 153
Metastasis results from preexisting variant cells within a malignant tumor.
###end article-title 153
###begin article-title 154
Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.
###end article-title 154
###begin article-title 155
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.
###end article-title 155
###begin article-title 156
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
###end article-title 156
###begin article-title 157
Spatial and temporal control of gene therapy using ionizing radiation.
###end article-title 157
###begin article-title 158
Radioresistance of Stat1 over-expressing tumor cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signaling. Int J Radiat Biol In Press
###end article-title 158
###begin article-title 159
###xml 40 45 <span type="species:ncbi:9606">human</span>
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
###end article-title 159
###begin article-title 160
###xml 23 28 <span type="species:ncbi:9606">human</span>
Molecular portraits of human breast tumours.
###end article-title 160
###begin article-title 161
Molecular portraits and the family tree of cancer.
###end article-title 161
###begin article-title 162
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer.
###end article-title 162
###begin article-title 163
Cancer metastasis: building a framework.
###end article-title 163
###begin article-title 164
Dissemination and growth of cancer cells in metastatic sites.
###end article-title 164
###begin article-title 165
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.
###end article-title 165
###begin article-title 166
Evidence for the clonal origin of spontaneous metastases.
###end article-title 166
###begin article-title 167
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Seeding and propagation of untransformed mouse mammary cells in the lung.
###end article-title 167
###begin article-title 168
STAT1 as a key modulator of cell death.
###end article-title 168
###begin article-title 169
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.
###end article-title 169
###begin article-title 170
Identification of JAK/STAT signalling components by genome-wide RNA interference.
###end article-title 170
###begin article-title 171
STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
###end article-title 171
###begin article-title 172
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis.
###end article-title 172
###begin article-title 173
###xml 61 66 <span type="species:ncbi:9606">human</span>
Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays.
###end article-title 173
###begin article-title 174
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
###end article-title 174
###begin article-title 175
Protein ISGylation modulates the JAK-STAT signaling pathway.
###end article-title 175
###begin article-title 176
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
###end article-title 176
###begin p 177
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 177
###begin p 178
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: These studies were supported by grants from the Ludwig Foundation and National Cancer Institute (CA111423 to RRW). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH and Ludwig foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.
###end p 178

